Press Release

June 21, 2022
1 min read

Jason Menzo named CEO of Foundation Fighting Blindness


Press Release

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The Foundation Fighting Blindness has promoted Jason Menzo to CEO and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration Fund, according to a press release.

The leadership changes will take effect July 1.

Ben Yerxa, PhD, who has served as CEO of the foundation since 2017, will transition to CEO of Opus Genetics.

Menzo joined the Foundation Fighting Blindness in 2018 and has served as president and chief operating officer since January 2022. Kelley previously served as the RD Fund’s senior vice president of investments and alliances.

“We’re grateful for Ben’s leadership in advancing therapies to address retinal disease and highlighting the patient voice — both during his tenure at the foundation and RD Fund, as well as throughout his more than 3-decade career translating research into clinical-stage and commercial products for the eye,” Menzo said in the release. “This is the beauty of the venture philanthropy model that we’ve pioneered with the RD Fund. We can collaborate closely, identify needs and respond seamlessly to advance the shared missions of our organizations to make a meaningful difference in the lives of those in our community.”